Cite
HARVARD Citation
Cramer, P. et al. (n.d.). Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all?. Leukemia & lymphoma. 57 (5), pp. 987-990. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cramer, P. et al. (n.d.). Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all?. Leukemia & lymphoma. 57 (5), pp. 987-990. [Online].